Table 1.
Summary of the impact of combination therapy, MFT and sequential application on useful therapeutic life and the spread of multi-resistant genotypes assuming drug usage typical in control scenarios
Policy | Impact |
---|---|
Sequential application |
Medium useful therapeutic life |
|
Low multi-drug resistance |
MFT |
Long useful therapeutic life |
|
Low multi-drug resistance |
Combination therapy |
Longest useful therapeutic life |
Extreme increase in multi-drug resistance |